Table 2.
N | ROR | PRR | IC | EBGM | |
---|---|---|---|---|---|
Drug | (95% two‐sided CI) | (χ 2) | (IC025) | (EBGM05) | |
Infliximab | 14 | 2.14 (1.2, 3.81) | 1.95 (7.03) | 0.96 (0.54) | 1.94 (1.2) |
Adalimumab | ABC | 1.66 (1.49, 1.84) | 1.57 (91.54) | 0.58 (0.52) | 1.5 (1.37) |
Abbreviations: CI, confidence interval; EBGM, empirical Bayesian geometric mean; PRR, proportional reporting ratio; ROR, reporting odds ratio.